GH Research (FRA:1KA) Short Percentage of Float


FRA:1KA GH Research PLC FRA:1KA
35 GF Score
Price €21.80
! 2 Warning Signs
View Full Analysis

What is GH Research Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:1KA vs BHVN, NUVB, GLUE: Short Percentage of Float Comparison

For the Biotechnology subindustry, GH Research's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GH Research Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GH Research's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where GH Research's Short Percentage of Float falls into.


FRA:1KA
35GF Score
GH Research PLC FRA:1KA
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GH Research Business Description

Other Exchanges GHRS:USA
Address Dawson Street, Joshua Dawson House, Dublin 2, IRL, D02 RY95
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
35GF Score

Get the complete analysis for FRA:1KA

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.80
Price